相关实验视频
Updated: Jan 11, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
埃塞俄比亚南部2型糖尿病患者的慢性并发症
Biniyam Demisse Andarge1, Desta Haftu Hayelom1, Sayih Mehari Degualem1
1College of Medicine and Health Science, Arba Minch University, Arba Minch, Ethiopia.
埃塞俄比亚近一半的2型糖尿病患者患有慢性并发症,强调需要更好的预防和管理. 关键因素包括年龄较大,糖尿病持续时间较长和血糖控制不佳.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 2型糖尿病 (T2DM) 是一个日益严重的全球健康挑战,埃塞俄比亚的患病率正在上升.
- 慢性并发症严重损害生活质量和压力医疗保健资源.
- 埃塞俄比亚对T2DM并发症及其导致因素的研究有限.
研究的目的:
- 为了确定T2DM患者慢性并发症的患病率.
- 确定与这些并发症相关的因素.
- 为改善埃塞俄比亚南部糖尿病护理策略提供信息.
主要方法:
- 一项基于设施的横截面研究与404名T2DM患者进行.
- 通过采访和医疗记录收集的数据包括人口统计,临床资料,自我护理和并发症.
- 多变量逻辑回归分析了与慢性并发症相关的因素.
主要成果:
- 几乎一半 (45.54%) 的T2DM患者至少有一种慢性并发症.
- 常见的并发症包括周围神经病变,病,充血性心力衰竭和脑血管疾病.
- 相关因素包括年龄较大,女性性别,糖尿病持续时间较长,血糖控制不佳,高三糖血症,高盐摄入量和身体不活动.
结论:
- 埃塞俄比亚南部的T2DM患者中存在大量的慢性并发症.
- 加强糖尿病护理需要对脂质,血压,HbA1c和脚部评估进行例行查.
- 基于社区的干预和患者教育对于预防和管理至关重要.
更多相关视频
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Chronic Kidney Disease II: Clinical Manifestations
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...